The unlikely rate hike by the Federal Reserve coupled with calmer conditions in the bond market boosted sentiments. Benchmark indices finished higher on hopes of economic reforms as the government......
Drug major Lupin on Tuesday said it has received US health regulator's approval to market generic version of ViiV Healthcare's Trizivir tablets, used in the treatment of HIV-1 infection, in the......
Domestic drug makers Cipla, Aurobindo and Matrix Laboratories have emerged as the second-line and paediatric AIDS medicine supply partners to international drug purchase facility UNITAID and......
Drug major GlaxoSmithKline's plan to patent its HIV/AIDS drug - Combivir - in India may hit a roadblock as a Kolkata-based NGO, Manipur Network of People Living with HIV/AIDS, has filed a pre-grant......
Aurobindo Pharma on Monday said it has received a tentative new drug approval from USFDA for its fixed dose combination product used for treating HIV-1 infection. \nThe new drug approval is for......